Shanghai MicroPort EP MedTech Future Growth
Future criteria checks 5/6
Shanghai MicroPort EP MedTech is forecast to grow earnings and revenue by 54.3% and 27.1% per annum respectively. EPS is expected to grow by 53.7% per annum. Return on equity is forecast to be 5.6% in 3 years.
Key information
54.3%
Earnings growth rate
53.7%
EPS growth rate
| Medical Equipment earnings growth | 26.4% |
| Revenue growth rate | 27.1% |
| Future return on equity | 5.6% |
| Analyst coverage | Good |
| Last updated | 29 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 808 | 117 | 66 | 132 | 8 |
| 12/31/2025 | 603 | 73 | 7 | 69 | 8 |
| 12/31/2024 | 441 | 41 | -21 | 34 | 8 |
| 9/30/2024 | 384 | 36 | 37 | 65 | N/A |
| 6/30/2024 | 385 | 21 | 7 | 37 | N/A |
| 3/31/2024 | 366 | 19 | -60 | -18 | N/A |
| 12/31/2023 | 329 | 6 | -80 | -38 | N/A |
| 9/30/2023 | 304 | 12 | -75 | -32 | N/A |
| 6/30/2023 | 281 | 4 | -82 | -39 | N/A |
| 3/31/2023 | 257 | -6 | -55 | -22 | N/A |
| 12/31/2022 | 260 | 3 | -41 | -9 | N/A |
| 9/30/2022 | 245 | -4 | -41 | -13 | N/A |
| 6/30/2022 | 221 | -7 | -26 | 2 | N/A |
| 3/31/2022 | 200 | -10 | -17 | 14 | N/A |
| 12/31/2021 | 190 | -12 | -16 | 21 | N/A |
| 12/31/2020 | 141 | 6 | -22 | 9 | N/A |
| 12/31/2019 | 117 | -15 | -10 | 0 | N/A |
| 12/31/2018 | 84 | -2 | 1 | 3 | N/A |
| 6/30/2018 | 77 | -5 | N/A | 7 | N/A |
| 3/31/2018 | 70 | -10 | N/A | -4 | N/A |
| 12/31/2017 | 62 | -14 | N/A | -14 | N/A |
| 9/30/2017 | 57 | -17 | N/A | -12 | N/A |
| 6/30/2017 | 53 | -19 | N/A | -9 | N/A |
| 3/31/2017 | 49 | -19 | N/A | -6 | N/A |
| 12/31/2016 | 46 | -19 | N/A | -3 | N/A |
| 12/31/2015 | 37 | -17 | N/A | -26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688351's forecast earnings growth (54.3% per year) is above the savings rate (2.8%).
Earnings vs Market: 688351's earnings (54.3% per year) are forecast to grow faster than the CN market (26.2% per year).
High Growth Earnings: 688351's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688351's revenue (27.1% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 688351's revenue (27.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688351's Return on Equity is forecast to be low in 3 years time (5.6%).